Theriva Biologics, Inc. (TOVX) Scorecard
- 2026-Q2: Total return Win; Revenue growth Lose; EPS growth Lose.
- 2026-Q1: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2025-Q4: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2025-Q3: Total return Lose; Revenue growth Lose; EPS growth Lose.
21/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 1 wins, 11 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q21/3 |
WinTOVX / S&P 25.00% / 15.20% |
LoseTOVX / S&P TOVX unavailable / 15.00% |
LoseTOVX / S&P -115.05% / 50.40% |
| 2026-Q10/3 |
LoseTOVX / S&P -4.76% / -4.33% |
LoseTOVX / S&P TOVX unavailable / 11.30% |
LoseTOVX / S&P -91.72% / 27.70% |
| 2025-Q40/3 |
LoseTOVX / S&P -48.78% / 2.65% |
LoseTOVX / S&P TOVX unavailable / 9.00% |
LoseTOVX / S&P -86.60% / 13.40% |
| 2025-Q30/3 |
LoseTOVX / S&P -4.65% / 8.12% |
LoseTOVX / S&P TOVX unavailable / 4.61% |
LoseTOVX / S&P -104.55% / 13.45% |
| 2025-Q20/3 |
LoseTOVX / S&P -60.91% / 10.94% |
LoseTOVX / S&P TOVX unavailable / 4.83% |
LoseTOVX / S&P -84.46% / 10.63% |
| 2025-Q10/3 |
LoseTOVX / S&P -37.14% / -4.27% |
LoseTOVX / S&P TOVX unavailable / 4.98% |
LoseTOVX / S&P -34.49% / 10.57% |
| 2024-Q42/3 |
WinTOVX / S&P 26.81% / 2.41% |
LoseTOVX / S&P TOVX unavailable / 5.25% |
WinTOVX / S&P 44.37% / 6.15% |
| 2024-Q31/3 |
LoseTOVX / S&P -77.00% / 5.89% |
LoseTOVX / S&P TOVX unavailable / 5.89% |
WinTOVX / S&P 459.19% / 6.11% |
| 2024-Q21/3 |
LoseTOVX / S&P -48.94% / 4.28% |
LoseTOVX / S&P TOVX unavailable / 5.38% |
WinTOVX / S&P 2160.87% / 5.12% |
| 2024-Q11/3 |
LoseTOVX / S&P 9.30% / 10.56% |
LoseTOVX / S&P TOVX unavailable / 5.71% |
WinTOVX / S&P 1477.27% / 5.59% |
| 2023-Q41/3 |
LoseTOVX / S&P -20.37% / 11.69% |
LoseTOVX / S&P TOVX unavailable / 6.81% |
WinTOVX / S&P 921.80% / 7.78% |
| 2023-Q31/3 |
LoseTOVX / S&P -46.00% / -3.27% |
LoseTOVX / S&P TOVX unavailable / 7.52% |
WinTOVX / S&P 363.28% / -5.03% |
| 2023-Q22/3 |
WinTOVX / S&P 42.86% / 8.74% |
LoseTOVX / S&P TOVX unavailable / 9.50% |
WinTOVX / S&P 12.20% / -8.57% |
| 2023-Q12/3 |
WinTOVX / S&P 55.56% / 7.50% |
LoseTOVX / S&P TOVX unavailable / 10.77% |
WinTOVX / S&P 10.92% / -15.69% |
| 2022-Q41/3 |
LoseTOVX / S&P -54.55% / 7.56% |
LoseTOVX / S&P TOVX unavailable / 11.88% |
WinTOVX / S&P 31.68% / -17.99% |
| 2022-Q31/3 |
LoseTOVX / S&P -52.86% / -4.88% |
LoseTOVX / S&P TOVX unavailable / 13.47% |
WinTOVX / S&P 68.42% / -1.41% |
| 2022-Q21/3 |
LoseTOVX / S&P -27.59% / -16.10% |
LoseTOVX / S&P TOVX unavailable / 13.71% |
WinTOVX / S&P 89.23% / 11.04% |
| 2022-Q11/3 |
WinTOVX / S&P 7.41% / -4.60% |
LoseTOVX / S&P TOVX unavailable / 15.97% |
LoseTOVX / S&P TOVX unavailable / 42.23% |
| 2021-Q40/3 |
LoseTOVX / S&P -41.30% / 11.03% |
LoseTOVX / S&P TOVX unavailable / 15.00% |
LoseTOVX / S&P TOVX unavailable / 96.40% |
| 2021-Q30/3 |
LoseTOVX / S&P -23.33% / 0.58% |
LoseTOVX / S&P TOVX unavailable / 10.77% |
LoseTOVX / S&P TOVX unavailable / 69.42% |
| 2021-Q20/3 |
LoseTOVX / S&P -11.76% / 8.55% |
LoseTOVX / S&P TOVX unavailable / 6.58% |
LoseTOVX / S&P TOVX unavailable / 51.81% |
| 2021-Q11/3 |
WinTOVX / S&P 78.95% / 6.17% |
LoseTOVX / S&P TOVX unavailable / -1.06% |
LoseTOVX / S&P TOVX unavailable / 7.39% |
| 2020-Q40/3 |
LoseTOVX / S&P -19.15% / 12.15% |
LoseTOVX / S&P TOVX unavailable / -3.72% |
LoseTOVX / S&P TOVX unavailable / -33.42% |
| 2020-Q30/3 |
LoseTOVX / S&P -7.84% / 8.93% |
LoseTOVX / S&P TOVX unavailable / -2.04% |
LoseTOVX / S&P TOVX unavailable / -27.10% |
| 2020-Q21/3 |
WinTOVX / S&P 59.38% / 20.54% |
LoseTOVX / S&P TOVX unavailable / -0.46% |
LoseTOVX / S&P TOVX unavailable / -27.11% |
| 2020-Q10/3 |
LoseTOVX / S&P -37.25% / -19.60% |
LoseTOVX / S&P TOVX unavailable / 3.47% |
LoseTOVX / S&P TOVX unavailable / -14.75% |
| 2019-Q41/3 |
WinTOVX / S&P 13.33% / 9.07% |
LoseTOVX / S&P TOVX unavailable / 5.36% |
LoseTOVX / S&P TOVX unavailable / 2.99% |
| 2019-Q30/3 |
LoseTOVX / S&P -18.18% / 1.70% |
LoseTOVX / S&P TOVX unavailable / 5.02% |
LoseTOVX / S&P TOVX unavailable / 0.21% |
| 2019-Q20/3 |
LoseTOVX / S&P -19.12% / 4.30% |
LoseTOVX / S&P TOVX unavailable / 6.64% |
LoseTOVX / S&P TOVX unavailable / 8.65% |
| 2019-Q11/3 |
WinTOVX / S&P 21.43% / 13.65% |
LoseTOVX / S&P TOVX unavailable / 8.12% |
LoseTOVX / S&P TOVX unavailable / 14.29% |
| 2018-Q40/3 |
LoseTOVX / S&P -78.46% / -13.52% |
LoseTOVX / S&P TOVX unavailable / 9.05% |
LoseTOVX / S&P TOVX unavailable / 18.23% |
| 2018-Q30/3 |
LoseTOVX / S&P -69.05% / 7.71% |
LoseTOVX / S&P TOVX unavailable / 10.21% |
LoseTOVX / S&P TOVX unavailable / 19.06% |
| 2018-Q20/3 |
LoseTOVX / S&P -25.00% / 3.43% |
LoseTOVX / S&P TOVX unavailable / 9.03% |
LoseTOVX / S&P TOVX unavailable / 14.46% |
| 2018-Q10/3 |
LoseTOVX / S&P -37.25% / -0.76% |
LoseTOVX / S&P TOVX unavailable / 7.68% |
LoseTOVX / S&P TOVX unavailable / 12.46% |
| 2017-Q40/3 |
LoseTOVX / S&P -45.16% / 6.64% |
LoseTOVX / S&P TOVX unavailable / 7.03% |
LoseTOVX / S&P TOVX unavailable / 13.82% |
| 2017-Q31/3 |
WinTOVX / S&P 63.16% / 4.48% |
LoseTOVX / S&P TOVX unavailable / 5.68% |
LoseTOVX / S&P TOVX unavailable / 17.57% |
| 2017-Q20/3 |
LoseTOVX / S&P -9.52% / 3.09% |
LoseTOVX / S&P TOVX unavailable / 4.83% |
LoseTOVX / S&P TOVX unavailable / 17.74% |
| 2017-Q10/3 |
LoseTOVX / S&P -17.11% / 6.07% |
LoseTOVX / S&P TOVX unavailable / 3.67% |
LoseTOVX / S&P TOVX unavailable / 13.32% |
| 2016-Q40/3 |
LoseTOVX / S&P -55.81% / 3.82% |
LoseTOVX / S&P TOVX unavailable / 2.09% |
LoseTOVX / S&P TOVX unavailable / 7.05% |
| 2016-Q30/3 |
LoseTOVX / S&P -4.44% / 3.85% |
LoseTOVX / S&P TOVX unavailable / 0.20% |
LoseTOVX / S&P TOVX unavailable / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | TOVX total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -39.02% | 20.78% |
| Annualized return | -39.02% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | TOVX total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -99.80% | 83.14% |
| Annualized return | -71.03% | 12.86% |
10Y · 2016-09-01 to 2026-08-27
| Metric | TOVX total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -100.00% | 319.30% |
| Annualized return | -66.47% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |